12
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Campylobacter pylori – Therapy Review

Pages 35-38 | Published online: 08 Jul 2009
 

Abstract

Although Campylobacter pylori is sensitive to many antibiotics in vitro, few are effective in vivo. Furthermore, treatment regimens which successfully clear the organism in vivo are associated with high recurrence rates when assessed one month following treatment. On the other hand, 85% of those individuals who are C. pylori negative 1 month after the cessation of therapy remain negative at 12 months and the infection can be considered to be eradicated. Treatment with certain bismuth salts appears to be the most useful monotherapy, eradicating the organism in approximately 19% whilst dual therapy with bismuth plus ampicillin or tinidazole is more effective, eradicating infection in 32% and 78% respectively. Preliminary data suggest that triple therapy with bismuth, amoxicillin and metronidazole, or bismuth, tetracycline and metronidazole eradicates the infection in over 90%.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.